Japanese scientists develop a new device for metronomic photodynamic therapy to facilitate a minimally-invasive and effective cancer treatment in delicate organs
Scientists from Waseda University, the National Defense Medical College, and the Japan Science and Technology Agency developed a new bioadhesive, wirelessly-powered light-emitting device which could better treat cancers in delicate organs.
Conventional photodynamic therapy induces cancer cell death by using photosensitizing agents, which localize in tumors and activate with exposure to a specific wavelength of light. In recent years, low-dose and long-term photodynamic therapy (metronomic photodynamic therapy, mPDT) has shown promise in treating cancers in internal organs. The problem with mPDT is, however, is that because the light intensity is extremely low (1/1000 of the conventional method), the antitumor effect cannot be obtained if the light source shifts even slightly away from the tumor, making the illumination insufficient.
“To address this issue, we have developed a wirelessly-powered optoelectronic device that stably fixes itself onto the inner surface of an animal tissue like a sticker with bioadhesive and elastic nanosheets, enabling a continuous, local light delivery to the tumor,” says Toshinori Fujie, associate professor of biomedical engineering at Waseda University. The nanosheets are modified with the mussel adhesive protein-inspired polymer polydopamine, which can stabilize the device onto a wet animal tissue for more than 2 weeks without surgical suturing or medical glue. The light-emitting diode chips in the device are wirelessly powered by near-field-communication technology.
To test its effectiveness, tumor-bearing mice implanted with the device were injected with a photosensitizing agent (photofrin) and exposed to red and green light, approximately 1,000-fold intensity lower than the conventional PDT approaches, for 10 consecutive days. The experiment showed that the tumor growth was significantly reduced overall. Especially under green light, the tumor in some mice was completely eradicated.
Associate Professor Fujie points out, “This device may facilitate treatment for hard-to-detect microtumors and deeply located lesions that are hard to reach with standard phototherapy, without having to worry about the risk of damaging healthy tissues by overheating. Furthermore, because the device does not require surgical suturing, it is suitable for treating cancer near major nerves and blood vessels, as well as for organs that are fragile, that change their shape, or that actively move, such as the brain, liver, and pancreas.”
If clinically applied, the device could be beneficial for cancer patients who seek minimally invasive treatment, helping them live longer and improve their quality of life.
Learn more: Bioadhesive, wirelessly-powered implant emitting light to kill cancer cells
The Latest on: Photodynamic therapy
[google_news title=”” keyword=”photodynamic therapy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Photodynamic therapy
- High Levels of Carbon Dioxide Increase Virus Survival and Transmissionon April 30, 2024 at 2:50 am
Scientists have discovered higher levels of carbon dioxide increase the survival of viruses in the air. These findings could serve as a scientific basis for designing mitigation strategies to reduce ...
- Microdroplets harness laser light to detect disease markerson April 28, 2024 at 5:00 pm
The microdroplets could be applied in photodynamic therapy, where patients receive a light-activated drug. These drugs, called photosensitisers, are designed to be absorbed only by diseased or ...
- Agricultural Biotechnology Market Size Set To Reach USD 232 Billion By 2032on April 25, 2024 at 7:00 am
According to Market.Us, the global agricultural biotechnology market was assessed at US$ 111 billion in 2022. Projections suggest it is poised to reach approximately US$ 232 billion by 2032. During ...
- ImPact Biotech to Present Interim Phase 3 Data from ENLIGHTED Study of Padeliporfin VTP in Low Grade UTUC at Upcoming Medical Conferenceson April 24, 2024 at 7:00 am
Preliminary results from Phase 3 ENLIGHTED study in low grade upper tract urothelial cancer (UTUC) to be presented at AUA and ASCO Trial design for Phase 1 study of Padeliporfin VTP in pancreatic ...
- First in the GCC: Niner Pharmaceuticals Launches Innovative Eye Treatmenton April 23, 2024 at 10:52 am
Niner Pharmaceuticals Launches Innovative Eye TreatmentDubai, Dubai, United Arab Emirates - April 23, 2024 — Niner ...
- Patients With Actinic Keratosis Prefer Simulated Daylight PDT Over More Painful Red Light PDTon April 22, 2024 at 10:08 am
A recent study found that patients with actinic keratosis experienced more pain during red light photodynamic therapy (PDT) than simulated daylight PDT, emphasizing the need to understand patient ...
- Could a Novel RNA-Based Vaccine Strategy Stop Endless Boosters?on April 22, 2024 at 8:13 am
A novel vaccination strategy utilizing small interfering RNA molecules could protect infants from COVID-19 and flu with a single shot. The study suggests that the vaccine strategy could offer ...
- Sales of Dermatology Devices Market to Grow at Robust CAGR 11.92% During 2031on April 22, 2024 at 7:43 am
The global dermatology devices market is experiencing a period of significant growth, supported by several key factors. This market study provides to a wide range of needs, encompassing both the ...
- Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Studyon April 18, 2024 at 1:22 pm
In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
via Bing News